A 30-year-old Connecticut man was killed early Sunday morning, Oct. 20, after driving the wrong way on a highway and crashing into an oncoming car in New Haven County, authorities said. Aron Tyrell ...

The “Thanksgiving grandma,” who accidentally texted a dinner invitation to a teen she’d never met, invited him anyway and ...

Novo Nordisk’s Alhemo® (concizumab) has been recommended for approval by the European Medicines Agency's (EMA) Committee for ...

Stephen Knight has saved thousands of animals from ending up in shelters. But 13 years ago, he was just trying to save himself.Knight, whose nonprofit provides fost ...

No serious adverse events; no grade 3 or higher adverse events reported Initial data from BEACON study expected week of ...

The clinic provides functional training and recommendations for assistive devices, allowing patients to adapt to their ...

Marstacimab is a human monoclonal immunoglobulin G type 1 antibody that enhances coagulation by targeting the Kunitz 2 domain of tissue factor pathway inhibitor.

The FDA has approved a new preventive treatment for people with certain types of hemophilia that can reduce bleeding episodes, sometimes down to just a few per year.

WINT Lead Drug Candidates, New Phase 2b Clinical Trial Data, Multiple Programs Focus on Unmet Needs In Cardiogenic Shock & ...